May 2, 2019
Sanofi’s dengue vaccine approved in USA
Sanofi’s dengue vaccien Dengvaxia was approved in the USA, the company said in a press release Thursday.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: vaccine
April 15, 2019
BiondVax universal flu vaccine patent application accepted in Australia
BiondVax Pharmaceuticals got its patent application covering formulation and production processes of the M-001 universal influenza vaccine candidate accepted in Australia.
March 27, 2019
IAVI Announces First-in-Human Clinical Trial of Native-like HIV Envelope Vaccine Candidate
Phase I Trial to Evaluate Safety and Immunogenicity of Engineered Envelope Protein NEW YORK–(BUSINESS WIRE)–The International AIDS Vaccine Initiative (IAVI)…
March 27, 2019
Vaxart Completes Dosing of the Lead-In Cohort in Bivalent Norovirus Vaccine Phase 1b Clinical Trial
First Oral Norovirus GII.4 Tablet Vaccine Used in Clinical Trial SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Vaxart, Inc., a clinical-stage biotechnology company…
March 18, 2019
China National Biotec Group (CNBG) and ImmunoBiology Ltd Enter Licensing Agreement to Co-Develop Next Generation Vaccine against Pneumococcal Disease in Greater China
Cambridge Based Vaccine Company ImmBio has entered a licensing agreement with the largest vaccine producer in China, CNBG to Co-Develop…
December 6, 2017
GSK’s Shingrix able to prevent shingles in autologous haematopoietic stem cell transplant patients
GlaxoSmithKline said on Wednesday that new data from a Phase III clinical study supports the safety and efficacy of Shingrix…
March 3, 2017
Sanofi, AstraZeneca making Respiratory Syncytial Virus vaccine
Sanofi’s vaccines global business unit Sanofi Pasteur has signed a deal with AstraZeneca’s biologics bramch MedImmune, to make and sell a monoclonal antibody-called MEDI8897-for the prevention of the most common reason for lower respiratory tract infections in newborns and infants, Respiratory Syncytial Virus (RSV).
January 4, 2017
Eli Lilly’s subsidiary Elanco buys BIVI
Eli Lilly’s subsidiary Elanco US has completed the acquisition of Boehringer Ingelheim Vetmedica, Inc’s (BIVI) U.S. feline, canine and rabies vaccines…
January 4, 2017
Sanofi enters New Year with new deal, ends its vaccine joint venture
Sanofi has starts new year with big changes. In two separate statements the company announced closing a deal and ending a joint venture.
March 10, 2016
Sanofi and MSD/Merck in joint vaccines operations in Europe
Sanofi and MSD/Merck in joint vaccines operations in Europe